Protecting the Eyes of Gamers With Lubricating Eyedrops
Launched by ASTON UNIVERSITY · Dec 1, 2023
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at whether a special lubricating eyedrop called TheaLoz Duo can help protect the eyes of gamers who spend a lot of time in front of screens. Many gamers experience dryness and discomfort in their eyes, which can be worsened by long gaming sessions. The study aims to find out if using these eyedrops can relieve symptoms of dry eyes and keep the surface of the eyes healthier for those who play handheld and computer games for at least two hours a day.
To participate, you need to be at least 18 years old and have symptoms of dry eyes. You should also be comfortable using smartphone apps and able to attend three visits over two months. During the study, you will either use the eyedrops first or not use them at all for a month, and then switch. Each visit will include eye health checks. This trial is important because it could help improve eye care for the growing number of gamers worldwide. If you’re interested, make sure you don’t have any recent eye surgeries or infections, and you should not be pregnant or using other eye medications during the study.
Gender
ALL
Eligibility criteria
- Inclusion criteria:
- • Individuals with dryness symptoms as assessed with the Ocular Surface Disease Index (OSDI score ≥ 13).
- • Individuals who play handheld console and computer-based games ≥ 2 hours everyday on average
- • Individuals who are comfortable and competent at using smartphone applications
- • Age ≥ 18 years, male or female
- • Able to provide written consent in English
- • Able to instil the treatment lubricating eyedrop on their own, and return any provided eyedrop bottle to the researcher used at the end of the treatment
- • Able to attend multiple visits (3 visits over 2 months)
- Exclusion criteria:
- • Pregnancy
- • Use of any topical ocular medical eyedrops or lubricants in the 1 week prior to starting the study or during the study period. Those who are using existing lubricating eyedrops and are interested in participating will be required to stop their lubricating eyedrops for 1 week prior to commencing the study
- • History of ocular surgery, trauma or infections in the past 6 months
About Aston University
Aston University is a leading research institution based in Birmingham, UK, renowned for its commitment to advancing knowledge and innovation across various disciplines, including health sciences. As a clinical trial sponsor, Aston University leverages its strong academic foundation and interdisciplinary expertise to conduct rigorous and ethical research aimed at improving patient outcomes and healthcare practices. The university fosters collaboration with healthcare professionals, industry partners, and regulatory bodies to ensure that its clinical trials adhere to the highest standards of scientific integrity and compliance, ultimately contributing to the advancement of medical science and public health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Birmingham, West Midlands, United Kingdom
Patients applied
Trial Officials
James S Wolffsohn, PhD
Study Director
Aston University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported